Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · IEX Real-Time Price · USD
5.76 0.23 (4.16%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap235.07M
Revenue (ttm)116.83M
Net Income (ttm)-1.86M
Shares Out40.81M
EPS (ttm)-0.05
PE Ration/a
Forward PE19.46
Dividendn/a
Ex-Dividend Daten/a
Volume242,311
Open5.50
Previous Close5.53
Day's Range5.48 - 5.84
52-Week Range3.87 - 8.75
Beta1.76
AnalystsStrong Buy
Price Target10.00 (+73.6%)
Earnings Daten/a

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equi...

IndustryLife Sciences Tools & Services
IPO DateDec 7, 2000
Employees428
Stock ExchangeNASDAQ
Ticker SymbolHBIO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for HBIO stock is "Strong Buy." The 12-month stock price forecast is 10.00, which is an increase of 73.61% from the latest price.

Price Target
$10.00
(73.61% upside)
Analyst Consensus: Strong Buy

News

Harvard Bioscience (HBIO) Q3 Earnings Meet Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0.00% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Harvard Bioscience Announces Third Quarter 2021 Financial Results

Strong double digit revenue growth, solid margin performance despite global supply chain disruptions

2 months ago - GlobeNewsWire

Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET

HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on Nov...

3 months ago - GlobeNewsWire

Harvard Bioscience (HBIO) Tops Q2 Earnings and Revenue Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 20.00% and 6.56%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Harvard Bioscience Announces Second Quarter 2021 Financial Results

Strong double digit revenue growth, solid margin performance despite global supply chain disruptions

5 months ago - GlobeNewsWire

Harvard Bioscience (HBIO) Reports Next Week: What to Know Ahead of the Release

Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET

HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5...

6 months ago - GlobeNewsWire

Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great Choice

Does Harvard Bioscience (HBIO) have what it takes to be a top stock pick for momentum investors? Let's find out.

6 months ago - Zacks Investment Research

Harvard Bioscience (HBIO) Is a Great Choice for "Trend" Investors, Here's Why

Harvard Bioscience (HBIO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed throu...

6 months ago - Zacks Investment Research

4 Breakout Stocks You Must Add Right Away to Your Portfolio

The logic behind this strategy for stock selection is to identify stocks that are trading within a narrow band.

Other symbols:DLTHGNKVEL
6 months ago - Zacks Investment Research

7 Stocks To Buy Right Now Under $10

Value investors look for inexpensive stocks that have growth potential. They often see low cost stocks as being on sale or undervalued.

7 months ago - InvestorPlace

5 Stocks with Solid Track Records at Attractive Prices

This is probably the time to focus on fundamentals because we don't want to overpay for stocks in a buoyant market.

Other symbols:AOSLARCBLGIHTGH
7 months ago - Zacks Investment Research

Surging Earnings Estimates Signal Upside for Harvard Bioscience (HBIO) Stock

Harvard Bioscience (HBIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

7 months ago - Zacks Investment Research

Harvard Bioscience (HBIO) Soars 8.3%: Is Further Upside Left in the Stock?

Harvard Bioscience (HBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow...

8 months ago - Zacks Investment Research

Harvard Bioscience (HBIO) Tops Q1 Earnings and Revenue Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 66.67% and 6.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Harvard Bioscience Announces First Quarter 2021 Financial Results

Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins

8 months ago - GlobeNewsWire

Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET

HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, ...

9 months ago - GlobeNewsWire

Harvard Bioscience: Q4 Earnings Insights

Shares of Harvard Bioscience (NASDAQ:HBIO) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share increased 0.00% year over year to $0.08, which beat the estimat...

10 months ago - Benzinga

Preview: Harvard Bioscience's Earnings

On Wednesday, March 10, Harvard Bioscience (NASDAQ:HBIO) will release its latest earnings report. Decipher the announcement with Benzinga's help.

10 months ago - Benzinga

Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET

HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on Marc...

11 months ago - GlobeNewsWire

Harvard Bioscience Announces New Credit Facility

HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (“Harvard Bioscience”) today announced the refinancing of its debt with the closing of a new $65 million credi...

1 year ago - GlobeNewsWire

Harvard Bioscience to attend Benchmark's 9th Annual Discovery One-on-One Conference

HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The B...

1 year ago - GlobeNewsWire

Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8:00 AM ET

HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on Novemb...

1 year ago - GlobeNewsWire

Harvard Bioscience to Present at Singular Research Compelling Values Webinar

HOLLISTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will present at the Singular Research Compelling Values ...

1 year ago - GlobeNewsWire